RENBP and metabolic dysfunction-associated steatotic liver disease: The top 15 pathways are displayed in Fig. 2D, with significant enrichment observed in pathways such as lipid and atherosclerosis (hsa05417), AGE-RAGE signaling pathway in diabetic complications (hsa04933), NAFLD (hsa04932), and insulin signaling pathway (hsa04910).